Introduction :

Dolphin Pharmaceuticals is a leading Fosaprepitant Dimeglumine supplier from India, based in Surat, Gujarat, specializing in the supply of high-quality specialty medicines. We serve pharmaceutical importers, distributors, hospitals, and healthcare organizations worldwide with quality-assured Fosaprepitant Dimeglumine.

Fosaprepitant Dimeglumine is primarily used for the treatment of chemotherapy induce nausea and vomiting, under the supervision of qualified healthcare professionals. Dolphin Pharmaceuticals is committed to providing authentic medicines, competitive pricing, complete support, global healthcare requirements.

Fosup 150 mg Injection

Fosup(Fosaprepitant Dimeglumine) Injection contains fosaprepitant dimeglumine, an antiemetic medicine belonging to the neurokinin-1 (NK1) receptor antagonist class. It is used to prevent acute and delayed nausea and vomiting associated with highly or moderately emetogenic chemotherapy, usually as part of a combination antiemetic regimen. Manufacturer: Zydus Lifesciences Limited. Country of origin: India.

Product Introduction

Fosaprepitant Dimeglumine 150 mg Injection is a prescription antiemetic medicine used to prevent nausea and vomiting associated with chemotherapy. It is particularly useful for controlling both the early and delayed phases of chemotherapy-induced nausea and vomiting.

Fosaprepitant Dimeglumine Injection is administered by a qualified healthcare professional under medical supervision. The dose and timing will be determined by your doctor based on your chemotherapy regimen and individual needs. Do not self-administer this medicine or change the prescribed dose. Your doctor may recommend regular monitoring, including liver function tests, during treatment.

Common side effects may include fatigue, headache, decreased appetite, constipation, indigestion, weakness, diarrhea, and hiccups. Some patients may experience dizziness or drowsiness. Avoid driving, operating machinery, or performing activities requiring mental alertness if you feel affected.

Uses of Fosaprepitant Dimeglumine 150 mg Injection

• Prevention of nausea and vomiting caused by chemotherapy

Benefits of Fosaprepitant Dimeglumine Injection

Chemotherapy-induced nausea and vomiting: Chemotherapy can cause nausea and vomiting, which may lead to dehydration, poor nutritional intake, weakness, and reduced quality of life. Fosaprepitant Dimeglumine 150 mg Injection helps prevent these symptoms by blocking the action of neurokinin-1 (NK1), a chemical signaling pathway involved in chemotherapy-induced vomiting. By controlling both acute and delayed nausea and vomiting, it can improve patient comfort and help patients continue their chemotherapy treatment as planned.

Side Effects of Fosaprepitant Dimeglumine 150 mg Injection

Most side effects are mild and may improve as the body adjusts to treatment. Consult your doctor if any side effect persists, worsens, or causes concern.

Commonly reported side effects include:

• Indigestion

• Fatigue

• Weakness

• Diarrhea

• Decreased white blood cell count (neutropenia)

• Anemia (low red blood cell count)

• Peripheral neuropathy (tingling or numbness in the hands and feet)

• Decreased lymphocyte count

• Urinary tract infection

• Pain in the extremities

• Headache

• Decreased appetite

• Constipation

• Hiccups

How Fosaprepitant Dimeglumine Works

Fosup150 mg Injection contains fosaprepitant, an antiemetic medicine. It is converted in the body to aprepitant and works by blocking neurokinin-1 (NK1) receptors in the brain.

These receptors are involved in the signaling pathway that triggers vomiting during and after chemotherapy. By blocking NK1 receptor activity, Fosuphelps prevent both the immediate and delayed phases of chemotherapy-induced nausea and vomiting.